Skin cancer is the most common cancer in America, yet millions of people never receive the annual skin exam doctors recommend. So what if your primary care physician could detect suspicious moles in seconds using AI?
In this episode of the Miami Tech Pod, Maria sits down with Cody Simmons, Co-Founder and CEO of DermaSensor, the company behind America's first FDA-authorized, AI-powered skin cancer detection device.
Cody shares the incredible eight-year journey from research project to commercialization — including miniaturizing a 30-pound laboratory machine into a handheld device, navigating the tough FDA approval process, raising venture capital, and building one of Miami's most promising medical technology companies.
They also discuss:
How DermaSensor works (and why it isn't just taking photos)
Why primary care doctors miss up to half of melanomas
The realities of building a healthcare startup versus software
The future of AI in preventative healthcare
Miami's evolution into a serious healthcare and technology hub
Podden och tillhörande omslagsbild på den här sidan tillhör
Miami Tech. Innehållet i podden är skapat av Miami Tech och inte av,
eller tillsammans med, Poddtoppen.
